|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5383 | (2006.01) |
| A61K 31/7064 | (2013.01) | ||
| A61K 31/7064 | (2006.01) | ||
| A61K 31/5383 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/4985 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 4013420 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20764496.4 |
| Date of filing the European patent application | 2020-08-13 | |
| (97) | Date of publication of the European application | 2022-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/046060 |
| Date | 2020-08-13 |
| (87) | Number | WO 2021/030526 |
| Date | 2021-02-18 |
| (30) | Number | Date | Country code |
| 201962886806 P | 2019-08-14 | US |
| (72) |
TAYLOR, Vanessa , US
ISSAKANI, Sarkiz , US
YOUNG, Chi , US
|
| (73) |
Rigel Pharmaceuticals, Inc. ,
611 Gateway Boulevard
Suite 900, South San Francisco, CA 94080,
US
|
| (54) | METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME |
| METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME |